|
|||||
|
|
A combination povidone-iodine 0.4%/dexamethasone 0.1% ophthalmic suspension in the treatment of adenoviral conjunctivitis |
|
| Authors: | J. S. Pelletier K. Stewart W. Trattler D. C. Ritterband S. Braverman C. M. Samson B. Liang J. A. Capriotti |
| Affiliation: | (1) Department of Ophthalmology, Fukuoka University School of Medicine, 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan;(2) Department of Ophthalmology, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama 232-0024, Japan;(3) Mitsubishi Kagaku Bio-clinical Laboratories, Inc., 30-1 Shimura 3-chome, Itabashi-ku, Tokyo 174-8555, Japan;(4) Department of Ophthalmology, Hokkaido University Graduate School of Medicine, 14 Jo Kita, 5 Nishi, Kita-ku, Sapporo 060-0814, Japan |
| Abstract: | IntroductionThe objective of this pilot study was to determine the preliminary efficacy of a novel ophthalmic suspension containing povidone-iodine 0.4% and dexamethasone 0.1% in the treatment of adenoviral conjunctivitis. |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |